Furthermore, in the context of hyperglycemia, hepatic expression and activation of FoxO6 significantly contribute to increased ApoC3 production, impairing plasma TG metabolism associated with aging in HFD-fed conditions. This evidence concerns the gene APOC3 and Hyperglycemia.